hrp0086p1-p809 | Syndromes: Mechanisms and Management P1 | ESPE2016

Early Treatment with rhGH in Patients with Prader-Willi Syndrome Results in Improved Height with No Respiratory Adverse Effects

Alatzoglou Kyriaki , Gopalakushnamoorthy Mahalakshmi , Trewella Emily , Mulla Aayesha , Tan Hui-Leng , Bridges Nicola

Background: Prader-Willi syndrome (PWS) is a complex genetic disorder caused by lack of expression of paternally inherited imprinted genes on Chr15q11-q13. rhGH has beneficial effects on growth, body composition and development. Starting age, dose titration and monitoring remain controversial.Objective: To study retrospectively children who presented in our multidisciplinary PWS clinic and assess response to rhGH treatment, auxology, IGF1 concentration a...